POSITIVE SEQUENCE BIOLOGY
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.
POSITIVE SEQUENCE BIOLOGY
Industry:
Biopharma Biotechnology Genetics
Founded:
2020-08-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.correctsequence.com
Total Employee:
1+
Status:
Active
Total Funding:
340 M CNY
Technology used in webpage:
Euro CrUX Dataset Pound Sterling CrUX Top 10m Japanese Yen
Similar Organizations
Alix Ventures
Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Drive Radical Advances in Human Health
Azenta Life Sciences
Azenta Life Sciences provides life sciences solutions.
Cellect Biotechnology
Cellect Biotechnology is a biotechnology company engaged in developing a novel technology platform.
Drug Farm
Drug Farm is a biotechnology company utilizing genetics and AI technologies to discover and develop innovative, immune-modulating therapies.
Genzyme
Genzyme Corporation (Genzyme) is a biotechnology company. The Company's product and service portfolio is focused on rare genetic disease
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
InventisBio
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Silenseed
Silenseed is a biopharmaceutical company that focuses on the development of cancer therapies.
Current Employees Featured
Chen Jia Founder @ Positive Sequence Biology
Founder
Xiaodun Mou Chief Executive Officer (CEO) @ Positive Sequence Biology
Chief Executive Officer (CEO)
Founder
Investors List
Boyu Capital
Boyu Capital investment in Series A - Positive Sequence Biology
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - Positive Sequence Biology
New Alliance Capital
New Alliance Capital investment in Series A - Positive Sequence Biology
Sequoia Capital China
Sequoia Capital China investment in Series A - Positive Sequence Biology
TF Capital
TF Capital investment in Series A - Positive Sequence Biology
Zoo Capital
Zoo Capital investment in Series A - Positive Sequence Biology
Sequoia Capital China
Sequoia Capital China investment in Angel Round - Positive Sequence Biology
Official Site Inspections
http://www.correctsequence.com
- Host name: 101.132.179.73
- IP address: 101.132.179.73
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Positive Sequence Biology"
CorrectSequence Therapeutics Co., Ltd. - Drug …
Nov 25, 2024 CorrectSequence Therapeutics (Correctseq) was established in August 2020 and is located in Shanghai, China. The company was founded by a team of four individuals, including Dr. Jia Chen and Dr. Bei Yang, professors …See details»
About Us-正序生物 - correctsequence.com
正序生物（CorrectSequence Therapeutics）是一家专注于新型基因编辑技术的生物医药公司，利用世界先进的碱基编辑体系，为罹患严重疾病的人们开发突破性精准基因编辑疗法，造福人类 …See details»
CorrectSequence Therapeutics - Crunchbase Company Profile
Organization. CorrectSequence Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. ... CorrectSequence Therapeutics closed its last funding round on …See details»
正序生物官网
正本清源 序写未来 正本清源 序写未来. 利用自主原创的碱基编辑体系，开发突破性精准疗法， 造福全球患者和家庭。 利用自主原创的碱基编辑体系，开发突破性精准疗法， 造福全球患者和 …See details»
正序生物官网 - correctsequence.com
Jia Chen, Co-founder of CorrectSequence Therapeutics to Participate in the 5th International Conference on Base Editing, Prime Editing & Related Enzymes. More. 2024-01-08. The …See details»
CorrectSequence Therapeutics - LinkedIn
CorrectSequence Therapeutics (Correctseq) is a clinical-stage biotech company employing its proprietary transformer base editing (tBE) technology to pioneer next-generation gene editing …See details»
Company: CorrectSequence Therapeutics
CorrectSequence (CorrectSeq) is a clinical-stage biotechnology company that focuses on the use of novel base editors to treat various severe genetic diseases. The company has …See details»
CorrectSequence Therapeutics - PitchBook
CorrectSequence Therapeutics General Information Description. Developer of gene editing technology intended to treat genetic diseases. The company develops base editing technology …See details»
CorrectSequence Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Correctseq - Products, Competitors, Financials, Employees, …
Correctsequence.com. Overview & Products; Financials; Founded Year 2020. Stage Series A - II | Alive. Total Raised $53.02M. Mosaic Score. The Mosaic Score is an algorithm that measures …See details»
CS-106 - Drug Targets, Indications, Patents - Synapse
CS-106, Initially developed by CorrectSequence Therapeutics Co., Ltd., Now, its global highest R&D status is Discovery, Therapeutic Areas: Infectious Diseases, Active ...See details»
CS-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
1 day ago CorrectSequence Therapeutics’ CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Thalassemia On January 8, 2024, Shanghai, China, …See details»
Series A - Positive Sequence Biology - 2024-08-08 - Crunchbase
Aug 8, 2024 Organization Name . Positive Sequence Biology . Announced Date Aug 8, 2024; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . obfuscated. …See details»
正序生物在中国成功开展首例临床基因编辑疗法治疗海外患者-动脉网
Aug 6, 2024 CorrectSequence TherapeuticsTM（CorrectseqTM）是一家临床阶段的生物技术公司，采用其专有的transformer Base Editor（tBE）来开创下一代基因编辑疗法。 ...See details»
Dr. Xiaodun Mou Joins CorrectSequence Therapeutics as CEO
Dec 8, 2021 CorrectSequence Therapeutics (Correctseq), founded in 2020, has announced the appointment of Dr. Xiaodun (Susan) Mou as the Chief Executive Officer (CEO), in charge of …See details»
The World's First Clinical Base Edting Therapy for Hemoglobinopathy
On January 8, 2024, Shanghai,China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), using innovative transformer Base Editing (tBE) technology to help people with severe …See details»
OBiO Technology Congratulates on The First Clinical Gene
SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- Recen tly, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for …See details»
正序生物最新临床结果被收录入EHA2024 Scientific Congress Report
Jul 19, 2024 正序生物正在快速高效地推进CS-101注射液治疗β-地中海贫血症的临床试验，同步也在筹备CS-101 注射液治疗 镰刀型贫血症 的临床试验，启动了 全球招募计划 （详情请联系 …See details»
Base Editing-正序生物 - correctsequence.com
Transformer Base Editor (tBE) with Ultra-high Editing Precision. tBE was developed with ultra-high editing precision to eliminate both gRNA-dependent and gRNA-independent off-target …See details»
Create an Organisation Chart: The Best Tips & Tricks
19 hours ago A clearly structured organisation chart increases efficiency in teams by making responsibilities and communication channels visible. A professionally designed organisation …See details»